0.3579
price up icon0.58%   0.002
 
loading
Precedente Chiudi:
$0.3559
Aprire:
$0.364
Volume 24 ore:
2.75M
Relative Volume:
0.38
Capitalizzazione di mercato:
$52.47M
Reddito:
$49.09M
Utile/perdita netta:
$-52.15M
Rapporto P/E:
-0.5506
EPS:
-0.65
Flusso di cassa netto:
$-45.93M
1 W Prestazione:
+18.84%
1M Prestazione:
-27.72%
6M Prestazione:
-72.04%
1 anno Prestazione:
-74.61%
Intervallo 1D:
Value
$0.34
$0.3679
Intervallo di 1 settimana:
Value
$0.2541
$0.5147
Portata 52W:
Value
$0.1718
$2.04

Biodesix Inc Stock (BDSX) Company Profile

Name
Nome
Biodesix Inc
Name
Telefono
303-417-0500
Name
Indirizzo
919 WEST DILLON ROAD, LOUISVILLE
Name
Dipendente
273
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-03
Name
Ultimi documenti SEC
Name
BDSX's Discussions on Twitter

Confronta BDSX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
BDSX
Biodesix Inc
0.358 32.24M 49.09M -52.15M -45.93M -0.65
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
393.90 152.86B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
184.97 136.66B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
499.86 41.18B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
108.29 32.05B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
136.51 24.29B 15.50B 1.33B 2.16B 7.34

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-14 Downgrade William Blair Outperform → Mkt Perform
2024-09-16 Iniziato Scotiabank Sector Outperform
2024-07-26 Iniziato Craig Hallum Buy
2024-05-13 Iniziato TD Cowen Buy
2024-05-03 Iniziato Lake Street Buy
2021-11-17 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-11-23 Iniziato BTIG Research Buy
2020-11-23 Iniziato Canaccord Genuity Buy
2020-11-23 Iniziato Morgan Stanley Overweight
2020-11-23 Iniziato William Blair Outperform
Mostra tutto

Biodesix Inc Borsa (BDSX) Ultime notizie

pulisher
May 22, 2025

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting | BDSX Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Biodesix to Present New Data on Host Immune Classifier for NSCLC at 2025 ASCO Annual Meeting - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Game-Changing Cancer Test Triples Survival Rate: New Clinical Data Transforms Lung Cancer Treatment - Stock Titan

May 22, 2025
pulisher
May 22, 2025

Biodesix (BDSX) Target Price Reduced to $2 by Scotiabank | BDSX Stock News - GuruFocus

May 22, 2025
pulisher
May 21, 2025

Biodesix Jumps 46% As Insider Buying, Retail Optimism Offset Scotiabank Target Cut By Stocktwits - Investing.com India

May 21, 2025
pulisher
May 21, 2025

Scotiabank cuts Biodesix stock target to $2, maintains outlook By Investing.com - Investing.com Canada

May 21, 2025
pulisher
May 21, 2025

Biodesix Approves Reverse Stock Split at Annual Meeting - TipRanks

May 21, 2025
pulisher
May 21, 2025

Scotiabank cuts Biodesix stock target to $2, maintains outlook - Investing.com

May 21, 2025
pulisher
May 21, 2025

Biodesix (BDSX) Sees Target Price Lowered by Scotiabank | BDSX S - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Biodesix to Participate in Upcoming Investor Conferences | BDSX Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Biodesix to Participate in Upcoming Investor Conferences - GlobeNewswire

May 21, 2025
pulisher
May 21, 2025

Biodesix Executives Set for Major Investor Conferences: William Blair and Craig-Hallum Presentations Ahead - Stock Titan

May 21, 2025
pulisher
May 20, 2025

Director’s Massive Stock Purchase Signals Confidence in Biodesix! - TipRanks

May 20, 2025
pulisher
May 19, 2025

Biodesix's (BDSX) "Market Perform" Rating Reaffirmed at William Blair - MarketBeat

May 19, 2025
pulisher
May 17, 2025

Craig Hallum Cuts Biodesix (NASDAQ:BDSX) Price Target to $1.50 - Defense World

May 17, 2025
pulisher
May 16, 2025

Biodesix revises 2025 revenue guidance to $80M–$85M amid sales force reconfiguration and primary care expansion - MSN

May 16, 2025
pulisher
May 16, 2025

Susquehanna International Group LLP Grows Stock Holdings in Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat

May 16, 2025
pulisher
May 16, 2025

Biodesix, Inc. (NASDAQ:BDSX) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Finance

May 16, 2025
pulisher
May 15, 2025

Biodesix, Inc. Earnings Call: Growth Amid Challenges - TipRanks

May 15, 2025
pulisher
May 15, 2025

Biodesix, Inc. (NASDAQ:BDSX) Q1 2025 Earnings Call Transcript - MSN

May 15, 2025
pulisher
May 15, 2025

Analysts Just Slashed Their Biodesix, Inc. (NASDAQ:BDSX) EPS Numbers - simplywall.st

May 15, 2025
pulisher
May 15, 2025

Biodesix Announces New Clinical and Economic Data for Its Nodify Lung® Tests At ISPOR and ATS - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

News Flash: 6 Analysts Think Biodesix, Inc. (NASDAQ:BDSX) Earnings Are Under Threat - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS | BDSX Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Biodesix, Inc. to Present New Data on Lung Cancer Diagnosis and Testing at ISPOR and ATS 2025 Conferences - Nasdaq

May 15, 2025
pulisher
May 15, 2025

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

New Clinical Data: Biodesix Lung Cancer Tests Could Prevent 60% of Unnecessary Invasive Procedures - Stock Titan

May 15, 2025
pulisher
May 15, 2025

Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award - GlobeNewswire

May 15, 2025
pulisher
May 14, 2025

Biodesix Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga

May 14, 2025
pulisher
May 14, 2025

Craig-Hallum Adjusts Price Target for Biodesix (BDSX) | BDSX Sto - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Diagnostic Leader Biodesix Clinches Elite Colorado Workplace Award, Employee Survey Reveals Why - Stock Titan

May 14, 2025
pulisher
May 14, 2025

Biodesix stock plunges as life-sciences firm cuts sales projection - BizWest

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX): Analyst Maintains Buy Rating Despite Lowered Pr - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Target Price Lowered by Lake Street Analyst | BD - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Canaccord cuts Biodesix stock target to $1.50, keeps buy rating By Investing.com - Investing.com Nigeria

May 14, 2025
pulisher
May 14, 2025

Biodesix stock target cut to $2 by TD Cowen, retains buy rating - Investing.com

May 14, 2025
pulisher
May 14, 2025

Biodesix, Inc. (BDSX) Reports Q1 Loss, Misses Revenue Estimates - MSN

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Target Price Lowered by Lake Street Analyst | BDSX Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix Inc Reports Q1 2025 Earnings: EPS of -$0.08 Misses Esti - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix stock rating cut to Market Perform at William Blair By Investing.com - Investing.com South Africa

May 14, 2025
pulisher
May 14, 2025

BDSX: Canaccord Genuity Lowers Price Target for Biodesix | BDSX Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Canaccord cuts Biodesix stock target to $1.50, keeps buy rating - Investing.com Australia

May 14, 2025
pulisher
May 14, 2025

BDSX Reports Q1 Revenue Below Expectations, Highlights Strategic - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix price target lowered to $1.50 from $2.50 at Canaccord - TipRanks

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Price Target Reduced as 2025 Revenue Outlook Dec - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix price target lowered to $1.50 from $3 at Craig-Hallum - TipRanks

May 14, 2025
pulisher
May 14, 2025

Biodesix price target lowered to $2 from $3 at TD Cowen - TipRanks

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Downgraded to Market Perform by William Blair | - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Target Price Reduced to $2 Amid Revenue Challeng - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Price Target Reduced as 2025 Revenue Outlook Declines | BDSX Stock News - GuruFocus

May 14, 2025

Biodesix Inc Azioni (BDSX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research DGX
$170.65
price up icon 0.62%
diagnostics_research LH
$241.61
price up icon 0.00%
diagnostics_research WAT
$343.17
price down icon 1.49%
$152.32
price down icon 0.02%
diagnostics_research MTD
$1,107.46
price down icon 2.54%
diagnostics_research IQV
$136.09
price down icon 1.46%
Capitalizzazione:     |  Volume (24 ore):